Armistice Capital, LLC 13D/13G Filings for BriaCell Therapeutics Corp. (BCTX)

Armistice Capital, LLC 13D and 13G filings for BriaCell Therapeutics Corp.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-08-15
12:24 pm
Purchase
2025-06-3013GBriaCell Therapeutics Corp.
BCTX
Armistice Capital, LLC33,600
8.310%
33,600increase
(New Position)
Filing